Literature DB >> 19864633

Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking.

Benjamin B Land1, Michael R Bruchas, Selena Schattauer, William J Giardino, Megumi Aita, Daniel Messinger, Thomas S Hnasko, Richard D Palmiter, Charles Chavkin.   

Abstract

Although stress has profound effects on motivated behavior, the underlying mechanisms responsible are incompletely understood. In this study we elucidate a functional pathway in mouse brain that encodes the aversive effects of stress and mediates stress-induced reinstatement of cocaine place preference (CPP). Activation of the dynorphin/kappa opioid receptor (KOR) system by either repeated stress or agonist produces conditioned place aversion (CPA). Because KOR inhibition of dopamine release in the mesolimbic pathway has been proposed to mediate the dysphoria underlying this response, we tested dopamine-deficient mice in this study and found that KOR agonist in these mice still produced CPA. However, inactivation of serotonergic KORs by injection of the KOR antagonist norBNI into the dorsal raphe nucleus (DRN), blocked aversive responses to the KOR agonist U50,488 and blocked stress-induced reinstatement of CPP. KOR knockout (KO) mice did not develop CPA to U50,488; however, lentiviral re-expression of KOR in the DRN of KOR KO mice restored place aversion. In contrast, lentiviral expression in DRN of a mutated form of KOR that fails to activate p38 MAPK required for KOR-dependent aversion, did not restore place aversion. DRN serotonergic neurons project broadly throughout the brain, but the inactivation of KOR in the nucleus accumbens (NAc) coupled with viral re-expression in the DRN of KOR KO mice demonstrated that aversion was encoded by a DRN to NAc projection. These results suggest that the adverse effects of stress may converge on the serotonergic system and offers an approach to controlling stress-induced dysphoria and relapse.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19864633      PMCID: PMC2776420          DOI: 10.1073/pnas.0910705106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain.

Authors:  V Zennou; C Serguera; C Sarkis; P Colin; E Perret; J Mallet; P Charneau
Journal:  Nat Biotechnol       Date:  2001-05       Impact factor: 54.908

2.  Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors.

Authors:  A Sirven; E Ravet; P Charneau; V Zennou; L Coulombel; D Guétard; F Pflumio; A Dubart-Kupperschmitt
Journal:  Mol Ther       Date:  2001-04       Impact factor: 11.454

3.  Positive and negative motivation in nucleus accumbens shell: bivalent rostrocaudal gradients for GABA-elicited eating, taste "liking"/"disliking" reactions, place preference/avoidance, and fear.

Authors:  Sheila M Reynolds; Kent C Berridge
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

Review 4.  Dopamine, learning and motivation.

Authors:  Roy A Wise
Journal:  Nat Rev Neurosci       Date:  2004-06       Impact factor: 34.870

Review 5.  MAPK cascade signalling and synaptic plasticity.

Authors:  Gareth M Thomas; Richard L Huganir
Journal:  Nat Rev Neurosci       Date:  2004-03       Impact factor: 34.870

Review 6.  Neurobiology of depression.

Authors:  Eric J Nestler; Michel Barrot; Ralph J DiLeone; Amelia J Eisch; Stephen J Gold; Lisa M Monteggia
Journal:  Neuron       Date:  2002-03-28       Impact factor: 17.173

7.  Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout mice.

Authors:  L B Hough; J W Nalwalk; Y Chen; A Schuller; Y Zhu; J Zhang; W M Menge; R Leurs; H Timmerman; J E Pintar
Journal:  Brain Res       Date:  2000-10-13       Impact factor: 3.252

8.  Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress.

Authors:  Marianne B Müller; Stephan Zimmermann; Inge Sillaber; Thomas P Hagemeyer; Jan M Deussing; Peter Timpl; Michael S D Kormann; Susanne K Droste; Ralf Kühn; Johannes M H M Reul; Florian Holsboer; Wolfgang Wurst
Journal:  Nat Neurosci       Date:  2003-09-14       Impact factor: 24.884

9.  Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects.

Authors:  Yukihiko Shirayama; Hisahito Ishida; Masaaki Iwata; Gen-I Hazama; Ryuzou Kawahara; Ronald S Duman
Journal:  J Neurochem       Date:  2004-09       Impact factor: 5.372

10.  Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.

Authors:  Elyssa B Margolis; Gregory O Hjelmstad; Antonello Bonci; Howard L Fields
Journal:  J Neurosci       Date:  2003-11-05       Impact factor: 6.167

View more
  162 in total

1.  Early role of the κ opioid receptor in ethanol-induced reinforcement.

Authors:  Ricardo Marcos Pautassi; Michael E Nizhnikov; Ma Belén Acevedo; Norman E Spear
Journal:  Physiol Behav       Date:  2012-01-11

Review 2.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

Review 3.  Ligand-directed signalling within the opioid receptor family.

Authors:  Amynah A Pradhan; Monique L Smith; Brigitte L Kieffer; Christopher J Evans
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

4.  6'-Guanidinonaltrindole (6'-GNTI) is a G protein-biased κ-opioid receptor agonist that inhibits arrestin recruitment.

Authors:  Marie-Laure Rives; Mary Rossillo; Lee-Yuan Liu-Chen; Jonathan A Javitch
Journal:  J Biol Chem       Date:  2012-06-26       Impact factor: 5.157

5.  Effectiveness of analogs of the kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) to reduce U50,488-induced diuresis and stress-induced cocaine reinstatement in rats.

Authors:  Patrick M Beardsley; Gerald T Pollard; James L Howard; F Ivy Carroll
Journal:  Psychopharmacology (Berl)       Date:  2010-04-07       Impact factor: 4.530

6.  Selective p38α MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction.

Authors:  Michael R Bruchas; Abigail G Schindler; Haripriya Shankar; Daniel I Messinger; Mayumi Miyatake; Benjamin B Land; Julia C Lemos; Catherine E Hagan; John F Neumaier; Albert Quintana; Richard D Palmiter; Charles Chavkin
Journal:  Neuron       Date:  2011-08-11       Impact factor: 17.173

7.  Tracking down the molecular substrates of stress: new roles for p38α MAPK and kappa-opioid receptors.

Authors:  John W Muschamp; Ashlee Van't Veer; William A Carlezon
Journal:  Neuron       Date:  2011-08-11       Impact factor: 17.173

8.  Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats.

Authors:  Stephanie L Grella; Douglas Funk; Kathy Coen; Zhaoxia Li; A D Lê
Journal:  Behav Brain Res       Date:  2014-02-28       Impact factor: 3.332

Review 9.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

10.  The effects of morphine, naloxone, and κ opioid manipulation on endocrine functioning and social behavior in monogamous titi monkeys (Callicebus cupreus).

Authors:  B J Ragen; N Maninger; S P Mendoza; K L Bales
Journal:  Neuroscience       Date:  2014-12-06       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.